ABSI
Price
$2.56
Change
-$0.14 (-5.19%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
403.71M
48 days until earnings call
BEAM
Price
$22.48
Change
-$0.42 (-1.83%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
2.32B
53 days until earnings call
Interact to see
Advertisement

ABSI vs BEAM

Header iconABSI vs BEAM Comparison
Open Charts ABSI vs BEAMBanner chart's image
Absci
Price$2.56
Change-$0.14 (-5.19%)
Volume$28K
Capitalization403.71M
Beam Therapeutics
Price$22.48
Change-$0.42 (-1.83%)
Volume$87.13K
Capitalization2.32B
ABSI vs BEAM Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. BEAM commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and BEAM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ABSI: $2.55 vs. BEAM: $22.49)
Brand notoriety: ABSI and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 72% vs. BEAM: 129%
Market capitalization -- ABSI: $403.71M vs. BEAM: $2.32B
ABSI [@Biotechnology] is valued at $403.71M. BEAM’s [@Biotechnology] market capitalization is $2.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABSI and BEAM are a good buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а +7.14% price change this week, while BEAM (@Biotechnology) price change was +13.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.32B) has a higher market cap than ABSI($404M). ABSI YTD gains are higher at: -2.672 vs. BEAM (-9.335). ABSI has higher annual earnings (EBITDA): -100.08M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. ABSI (117M). ABSI has less debt than BEAM: ABSI (7.41M) vs BEAM (155M). BEAM has higher revenues than ABSI: BEAM (60.3M) vs ABSI (4.14M).
ABSIBEAMABSI / BEAM
Capitalization404M2.32B17%
EBITDA-100.08M-414.33M24%
Gain YTD-2.672-9.33529%
P/E RatioN/AN/A-
Revenue4.14M60.3M7%
Total Cash117M1.15B10%
Total Debt7.41M155M5%
TECHNICAL ANALYSIS
Technical Analysis
ABSIBEAM
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADGCX17.21N/A
N/A
AB Core Opportunities C
MDLVX30.72N/A
N/A
BlackRock Advantage Large Cap Val Inv A
SSSYX497.49N/A
N/A
State Street Equity 500 Index K
BGITX15.26-0.01
-0.03%
Baillie Gifford International Alpha 2
SROAX13.79-0.01
-0.07%
Calamos Antetokounmpo Sustainable Eqs A